Intravenous thrombolysis for acute ischemic stroke in COVID-19 era: Still the same?

Bakola, Eleni; Giannopoulos, Sotirios

Bakola, Eleni; Giannopoulos, Sotirios.

Bakola E; Second Department of Neurology, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Giannopoulos S; Second Department of Neurology, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Acta Neurol Scand ; 145(2): 125-126, 2022 02.

Article in English | MEDLINE | ID: covidwho-1583696

Subject(s)

Brain Ischemia; COVID-19; Ischemic Stroke; Administration, Intravenous; Brain Ischemia/complications; Brain Ischemia/drug therapy; COVID-19/complications; Fibrinolytic Agents/therapeutic use; Humans; Ischemic Stroke/complications; Ischemic Stroke/drug therapy; Thrombolytic Therapy; Tissue Plasminogen Activator/therapeutic use; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Ischemia / Ischemic Stroke / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Acta Neurol Scand Year: 2022 Document Type: Article Affiliation country: Ane.13545

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google